$MASS
908 Devices Inc.

2024 Q4 Form 10-Q Financial Statement

#000155837024015175 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $16.77M
YoY Change 17.32%
Cost Of Revenue $8.441M
YoY Change 31.32%
Gross Profit $8.332M
YoY Change 5.88%
Gross Profit Margin 49.68%
Selling, General & Admin $13.38M
YoY Change 17.14%
% of Gross Profit 160.57%
Research & Development $6.788M
YoY Change 22.59%
% of Gross Profit 81.47%
Depreciation & Amortization $1.413M
YoY Change 90.95%
% of Gross Profit 16.96%
Operating Expenses $38.55M
YoY Change 127.32%
Operating Profit -$30.22M
YoY Change 232.46%
Interest Expense $879.0K
YoY Change -351.14%
% of Operating Profit
Other Income/Expense, Net $850.0K
YoY Change -55.47%
Pretax Income -$29.37M
YoY Change 309.01%
Income Tax -$72.00K
% Of Pretax Income
Net Earnings -$29.30M
YoY Change 313.01%
Net Earnings / Revenue -174.66%
Basic Earnings Per Share -$0.84
Diluted Earnings Per Share -$0.84
COMMON SHARES
Basic Shares Outstanding 34.82M 34.66M
Diluted Shares Outstanding 34.67M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $71.69M
YoY Change -51.53%
Cash & Equivalents $45.03M
Short-Term Investments $26.66M
Other Short-Term Assets $2.749M
YoY Change -11.32%
Inventory $17.83M
Prepaid Expenses
Receivables $16.66M
Other Receivables $0.00
Total Short-Term Assets $108.9M
YoY Change -39.43%
LONG-TERM ASSETS
Property, Plant & Equipment $3.666M
YoY Change 28.45%
Goodwill $10.14M
YoY Change 2.11%
Intangibles $46.68M
YoY Change 502.98%
Long-Term Investments
YoY Change
Other Assets $1.386M
YoY Change -4.22%
Total Long-Term Assets $69.36M
YoY Change 142.1%
TOTAL ASSETS
Total Short-Term Assets $108.9M
Total Long-Term Assets $69.36M
Total Assets $178.3M
YoY Change -14.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.895M
YoY Change -26.58%
Accrued Expenses $7.667M
YoY Change 5.5%
Deferred Revenue $13.86M
YoY Change 31.73%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.72M
YoY Change 15.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $3.359M
YoY Change -75.66%
Total Long-Term Liabilities $3.359M
YoY Change -75.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.72M
Total Long-Term Liabilities $3.359M
Total Liabilities $47.24M
YoY Change 22.57%
SHAREHOLDERS EQUITY
Retained Earnings -$223.4M
YoY Change 36.89%
Common Stock $35.00K
YoY Change 9.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $131.0M
YoY Change
Total Liabilities & Shareholders Equity $178.3M
YoY Change -14.48%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$29.30M
YoY Change 313.01%
Depreciation, Depletion And Amortization $1.413M
YoY Change 90.95%
Cash From Operating Activities -$5.607M
YoY Change 21.89%
INVESTING ACTIVITIES
Capital Expenditures $156.0K
YoY Change -22.0%
Acquisitions
YoY Change
Other Investing Activities $3.946M
YoY Change -140.68%
Cash From Investing Activities $3.790M
YoY Change -138.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 23.00K
YoY Change -109.2%
NET CHANGE
Cash From Operating Activities -5.607M
Cash From Investing Activities 3.790M
Cash From Financing Activities 23.00K
Net Change In Cash -1.794M
YoY Change -87.85%
FREE CASH FLOW
Cash From Operating Activities -$5.607M
Capital Expenditures $156.0K
Free Cash Flow -$5.763M
YoY Change 20.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
dei Entity Central Index Key
EntityCentralIndexKey
0001555279
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34670638
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32345925
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33817613
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32171685
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32519023
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34712488
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
CY2024Q3 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#PrimeRateMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39815
dei Entity Registrant Name
EntityRegistrantName
908 DEVICES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-4524096
dei Entity Address Address Line1
EntityAddressAddressLine1
645 Summer Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02210
dei City Area Code
CityAreaCode
857
dei Local Phone Number
LocalPhoneNumber
254-1500
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MASS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34822836
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45025000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121041000
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
26661000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
24641000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
585000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
395000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16659000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8989000
CY2024Q3 us-gaap Inventory Net
InventoryNet
17833000
CY2023Q4 us-gaap Inventory Net
InventoryNet
14938000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2749000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4181000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
108927000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
173790000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7484000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6233000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3666000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3342000
CY2024Q3 us-gaap Goodwill
Goodwill
10137000
CY2023Q4 us-gaap Goodwill
Goodwill
10367000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46683000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7860000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1386000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1389000
CY2024Q3 us-gaap Assets
Assets
178283000
CY2023Q4 us-gaap Assets
Assets
202981000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1895000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1191000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7667000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8713000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
13859000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10629000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2297000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2016000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
25718000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22549000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4882000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3929000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11027000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8571000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2258000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2441000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3359000
CY2024Q3 us-gaap Liabilities
Liabilities
47244000
CY2023Q4 us-gaap Liabilities
Liabilities
37490000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34712488
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32519023
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
35000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
33000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
352795000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
334692000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1568000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1365000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-223359000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170599000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
131039000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
165491000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178283000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
202981000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16773000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14297000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40811000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35878000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
8441000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
6428000
us-gaap Cost Of Revenue
CostOfRevenue
20058000
us-gaap Cost Of Revenue
CostOfRevenue
17831000
CY2024Q3 us-gaap Gross Profit
GrossProfit
8332000
CY2023Q3 us-gaap Gross Profit
GrossProfit
7869000
us-gaap Gross Profit
GrossProfit
20753000
us-gaap Gross Profit
GrossProfit
18047000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6788000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5537000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18959000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16460000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13379000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11317000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39877000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34297000
CY2024Q3 mass Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
12141000
CY2023Q3 mass Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-104000
mass Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
12141000
mass Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-335000
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
30523000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
30523000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
38549000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
16958000
us-gaap Operating Expenses
OperatingExpenses
77218000
us-gaap Operating Expenses
OperatingExpenses
51092000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-30217000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9089000
us-gaap Operating Income Loss
OperatingIncomeLoss
-56465000
us-gaap Operating Income Loss
OperatingIncomeLoss
-33045000
CY2024Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
879000
CY2023Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1449000
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3741000
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
4155000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-350000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
201000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-29000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
110000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-247000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-88000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
850000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1909000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3494000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3866000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29367000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7180000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52971000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29179000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-72000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-87000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-211000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-209000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-29295000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7093000
us-gaap Net Income Loss
NetIncomeLoss
-52760000
us-gaap Net Income Loss
NetIncomeLoss
-28970000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34670638
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32345925
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33817613
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33817613
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32171685
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32171685
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-29295000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7093000
us-gaap Net Income Loss
NetIncomeLoss
-52760000
us-gaap Net Income Loss
NetIncomeLoss
-28970000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
683000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-404000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
188000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-170000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
27000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
248000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
15000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
360000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
710000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-156000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
203000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
190000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28585000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7249000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-52557000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28780000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
165491000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
61000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2643000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-10917000
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-370000
CY2024Q1 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
15000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
156893000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
97000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3096000
CY2024Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
8617000
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
326000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-12548000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-125000
CY2024Q2 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
3000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
156359000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
66000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3199000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-29295000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
683000
CY2024Q3 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
27000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
131039000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
190599000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
88000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2166000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-12532000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
291000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
180612000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
301000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2578000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
259000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9346000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-57000
CY2023Q2 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
112000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
174459000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2704000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7093000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-404000
CY2023Q3 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
248000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
169929000
us-gaap Profit Loss
ProfitLoss
-52760000
us-gaap Profit Loss
ProfitLoss
-28970000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
30523000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3245000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1979000
us-gaap Share Based Compensation
ShareBasedCompensation
8938000
us-gaap Share Based Compensation
ShareBasedCompensation
7448000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-206000
us-gaap Inventory Write Down
InventoryWriteDown
527000
us-gaap Inventory Write Down
InventoryWriteDown
284000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
86000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-54000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
190000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
92000
mass Fair Value Adjustment Of Contingent Consideration
FairValueAdjustmentOfContingentConsideration
12141000
mass Fair Value Adjustment Of Contingent Consideration
FairValueAdjustmentOfContingentConsideration
-335000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-210000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-239000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6901000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2950000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2996000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3841000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1478000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-516000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
210000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
464000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1228000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1694000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
884000
mass Increase Decrease In Right Of Use Operating Assets
IncreaseDecreaseInRightOfUseOperatingAssets
-1493000
mass Increase Decrease In Right Of Use Operating Assets
IncreaseDecreaseInRightOfUseOperatingAssets
-1222000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1510000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1113000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28004000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23129000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
412000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1712000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
40879000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
34258000
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
44783000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
38973000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
4934000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47101000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31036000
mass Payments For Withholding Taxes On Vested Awards
PaymentsForWithholdingTaxesOnVestedAwards
1039000
mass Payments For Withholding Taxes On Vested Awards
PaymentsForWithholdingTaxesOnVestedAwards
598000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
551000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
663000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15000000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
417000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1095000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-905000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16030000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-76016000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-70209000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121212000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188593000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45196000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118384000
mass Property And Equipment Included In Account Payable
PropertyAndEquipmentIncludedInAccountPayable
36000
mass Transfers Of Inventory To Property And Equipment
TransfersOfInventoryToPropertyAndEquipment
999000
mass Transfers Of Inventory To Property And Equipment
TransfersOfInventoryToPropertyAndEquipment
342000
us-gaap Stock Issued1
StockIssued1
8616000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45025000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118213000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
171000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
171000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45196000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118384000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2012-02-10
us-gaap Net Income Loss
NetIncomeLoss
-52800000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-36400000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-223400000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, revenue recognition and accounts receivable, the valuation of inventory, fair value of assets acquired and liabilities assumed in acquisitions, estimated fair value used to record impairment charges related to goodwill, fair value of contingent consideration, and the valuation of stock-based awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Due to the impact of inflation and changes in interest rates, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require further updates to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates may change, as new events occur and additional information is obtained. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results may differ from those estimates or assumptions.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risk of Concentrations of Credit, Significant Customers and Significant Suppliers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The Company’s cash and cash equivalents and restricted cash are maintained in bank deposit accounts and money market funds that regularly exceed federally insured limits. The Company is exposed to credit risk on its cash, cash equivalents and restricted cash in the event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s marketable securities are invested in U.S. treasury securities and as a result, the Company believes represent minimal credit risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Significant customers are those that accounted for 10% or more of the Company’s total revenue or accounts receivable. For the three months ended September 30, 2024, one customer represented 21% of total revenue. For the comparable three months ended September 30, 2023, two customers represented 41% and 17% of total revenue, respectively. For the nine </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">months ended September 30, 2024, one customer represented 10% of total revenue. For the comparable nine months ended September 30, 2023, two customers represented 22% and 11% of total revenue. As of September 30, 2024, three customers accounted for 27%, 18% and 13% of gross accounts receivable. As of December 31, 2023, one customer accounted for 19% of gross accounts receivable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain of the components included in the Company’s products are obtained from a sole source, a single source or a limited group of suppliers. Although the Company seeks to reduce dependence on those limited sources of suppliers and manufacturers, the partial or complete loss of certain of these sources, or the requirement to establish a new supplier for the components, could have a material adverse effect on the Company’s operating results, financial condition and cash flows and damage its customer relationships.</p>
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
585000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
133000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
395000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
22000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
212000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
108000
CY2024Q3 mass Allowance For Doubtful Accounts Receivable Net Recoveries Deductions
AllowanceForDoubtfulAccountsReceivableNetRecoveriesDeductions
-22000
CY2023Q3 mass Allowance For Doubtful Accounts Receivable Net Recoveries Deductions
AllowanceForDoubtfulAccountsReceivableNetRecoveriesDeductions
-16000
mass Allowance For Doubtful Accounts Receivable Net Recoveries Deductions
AllowanceForDoubtfulAccountsReceivableNetRecoveriesDeductions
-22000
mass Allowance For Doubtful Accounts Receivable Net Recoveries Deductions
AllowanceForDoubtfulAccountsReceivableNetRecoveriesDeductions
-16000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
585000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
117000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
585000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
117000
us-gaap Debt Securities Available For Sale Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff
0
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
13859000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10629000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5254000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5080000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5773000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3491000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
24886000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
19200000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16773000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14297000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40811000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35878000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14297000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35878000
CY2023Q4 mass Accumulated Accretion And Relative Contingent Consideration
AccumulatedAccretionAndRelativeContingentConsideration
0
mass Deduction In Fair Value Of Contingent Consideration Earnout
DeductionInFairValueOfContingentConsiderationEarnout
12100000
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
500000
mass Acquisition Date Fair Value Of Contingent Consideration Earnout
AcquisitionDateFairValueOfContingentConsiderationEarnout
15500000
mass Deduction In Fair Value Of Contingent Consideration Earnout
DeductionInFairValueOfContingentConsiderationEarnout
12141000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
500000
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3359000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11500000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11294000
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1894000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1717000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4439000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1927000
CY2024Q3 us-gaap Inventory Net
InventoryNet
17833000
CY2023Q4 us-gaap Inventory Net
InventoryNet
14938000
mass Inventory Non Cash Transfers To Property Plant And Equipment
InventoryNonCashTransfersToPropertyPlantAndEquipment
1000000.0
mass Inventory Non Cash Transfers To Property Plant And Equipment
InventoryNonCashTransfersToPropertyPlantAndEquipment
300000
CY2024Q3 us-gaap Goodwill
Goodwill
10100000
CY2023Q4 us-gaap Goodwill
Goodwill
10367000
CY2022Q4 us-gaap Goodwill
Goodwill
10050000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
30160000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
30523000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
133000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-122000
CY2024Q3 us-gaap Goodwill
Goodwill
10137000
CY2023Q3 us-gaap Goodwill
Goodwill
9928000
CY2024Q3 mass Control Premium Percentage
ControlPremiumPercentage
0.20
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
30500000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
49004000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3063000
us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
742000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46683000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8424000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1220000
CY2023 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
656000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7860000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
930000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
221000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1843000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
658000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
928000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3710000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3641000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3632000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3632000
CY2024Q3 mass Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
31140000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46683000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5382000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5994000
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
896000
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
942000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
874000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
560000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
500000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
515000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
717000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7667000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8713000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
942000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1119000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
958000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
367000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1004000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
477000
CY2024Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
896000
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1009000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 mass Number Of Vote For Each Share Of Common Stock
NumberOfVoteForEachShareOfCommonStock
1
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5721819
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4541439
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3199000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2704000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8938000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7448000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
684000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
579000
us-gaap Operating Lease Cost
OperatingLeaseCost
1869000
us-gaap Operating Lease Cost
OperatingLeaseCost
1548000
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
24000
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
17000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
75000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
49000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
36000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
43000
us-gaap Variable Lease Cost
VariableLeaseCost
113000
us-gaap Variable Lease Cost
VariableLeaseCost
97000
CY2024Q3 us-gaap Lease Cost
LeaseCost
744000
CY2023Q3 us-gaap Lease Cost
LeaseCost
639000
us-gaap Lease Cost
LeaseCost
2057000
us-gaap Lease Cost
LeaseCost
1694000
us-gaap Operating Lease Payments
OperatingLeasePayments
1882000
us-gaap Operating Lease Payments
OperatingLeasePayments
1513000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2740000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3003000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y11M15D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.081
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.084
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
694000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2310000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
947000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
973000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
937000
CY2024Q3 mass Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
3373000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9234000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2055000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7179000
CY2021Q4 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2021Q4 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
CY2021Q4 mass Defined Contribution Plan Employer Matching Contribution Annual Maximum Per Employee
DefinedContributionPlanEmployerMatchingContributionAnnualMaximumPerEmployee
3500
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
500000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000
CY2023Q4 mass Accumulated Accretion And Relative Contingent Consideration
AccumulatedAccretionAndRelativeContingentConsideration
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
11150000
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
9575000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-015175-index-headers.html Edgar Link pending
0001558370-24-015175-index.html Edgar Link pending
0001558370-24-015175.txt Edgar Link pending
0001558370-24-015175-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mass-20240930.xsd Edgar Link pending
mass-20240930x10q.htm Edgar Link pending
mass-20240930x10q_htm.xml Edgar Link completed
mass-20240930xex31d1.htm Edgar Link pending
mass-20240930xex31d2.htm Edgar Link pending
mass-20240930xex32d1.htm Edgar Link pending
mass-20240930xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
mass-20240930_cal.xml Edgar Link unprocessable
mass-20240930_def.xml Edgar Link unprocessable
mass-20240930_lab.xml Edgar Link unprocessable
mass-20240930_pre.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable